Company intelligence / Profile preview
Oxford Pharmascience
London, England, United Kingdomoxfordpharmascience.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The company commercializes its own range of soft chew supplements under the Ellactiva® brand in multiple regions. Its proprietary OXPZero™ technology enables better-tasting, easier-to-take versions of existing medicines such as ibuprofen. It licenses these technologies to pharmaceutical partners rather than directly marketing prescription drugs itself. No recent clinical trial results are publicly available.
- Therapeutic areas
- OtherEndocrinologyRheumatology
- Modalities
- Small molecules (NSAIDs reformulation)Food supplements/chewable nutraceuticalsProprietary drug delivery systems
- Industry
- Drug Discovery Services
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Hermes Pharma/Hermes Arzneimittel GmbH – licensing/development partnership for orally disintegrating ibuprofen granules using OXPZero™ technology
Beyond the preview
Go deeper on Oxford Pharmascience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oxford Pharmascience.